Competing risk model in screening for preeclampsia by mean arterial pressure and uterine artery pulsatility index at 30-33 weeks' gestation

Fetal Diagnosis and Therapy

Volumn 36, Issue 1, 2014, Pages 18-27

  Tayyar, Ahmet ^a   Garcia Tizon Larroca, Santiago ^a   Poon, Leona C ^a   Wright, David ^b   Nicolaides, Kypros H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

Mean arterial pressure; Preeclampsia; Pyramid of pregnancy care; Uterine artery Doppler

Indexed keywords

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CARDIOVASCULAR PARAMETERS; DELIVERY; FEMALE; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MEAN ARTERIAL PRESSURE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRENATAL SCREENING; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMALL FOR DATE INFANT; SURVIVAL TIME; THIRD TRIMESTER PREGNANCY; UTERINE ARTERY; UTERINE ARTERY PULSATILITY INDEX; ARTERIAL PRESSURE; BIOLOGICAL MODEL; FIRST TRIMESTER PREGNANCY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES; PROSPECTIVE STUDY; PULSATILE FLOW; DOPPLER ECHOGRAPHY; FERTILIZATION IN VITRO; HYPERTENSION; MATERNAL AGE; MATERNAL CARE; PATIENT CARE; PYRAMID OF PREGNANCY CARE; REGRESSION ANALYSIS; SCREENING; STATISTICAL MODEL;

ADULT; ARTERIAL PRESSURE; FEMALE; GESTATIONAL AGE; HUMANS; MODELS, BIOLOGICAL; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; PULSATILE FLOW; UTERINE ARTERY;

EID: 84902941915     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000360792     Document Type: Article

References (34)

1. World Health Organization: Make Every Mother and Child Count. World Health Report, 2005. Geneva, WHO, 2005
2. Confidential Enquiry into Maternal and Child Health (CEMACH) Perinatal Mortality 2006: England, Wales and Northern Ireland. London, CEMACH, 2008
3. Duley L: The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33: 130-137
4. Nicolaides KH: Turning the pyramid of prenatal care. Fetal Diagn Ther 2011; 29: 183-196
5. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH: First-Trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009; 53: 812-818
6. Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH: Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 2011; 31: 66-74
7. Wright D, Akolekar R, Syngelaki A, Poon LC, Nicolaides KH: A competing risks model in early screening for preeclampsia. Fetal Diagn Ther 2012; 32: 171-178
8. Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH: Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther 2013; 33: 8-15
9. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguere Y: Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: A meta-Analysis. Obstet Gynecol 2010; 116: 402-414
10. Roberge S, Villa P, Nicolaides K, Giguere Y, Vainio M, Bakthi A, Ebrashy A, Bujold E: Early administration of low dose aspirin for the prevention of preterm and term pre-eclampsia: A systematic review and meta-Analysis. Fetal Diagn Ther 2012; 31: 141-146
11. Koopmans CM, Bijlenga D, Groen H, Vijgen SM, Aarnoudse JG, Bekedam DJ, van Den Berg PP, de Boer K, Burggraaff JM, Bloemenkamp KW, Drogtrop AP, Franx A, de Groot CJ, Huisjes AJ, Kwee A, van Loon AJ, Lub A, Papatsonis DN, van Der Post JA, Roumen FJ, Scheepers HC, Willekes C, Mol BW, van Pampus MG; HYPITAT Study Group: Induction of labour versus expectant monitoring for gestational hypertension or mild preeclampsia after 36 weeks' gestation (HYPITAT): A multicentre, open-label randomised controlled trial. Lancet 2009; 374: 979-988
12. Robinson HP, Fleming JE: A critical evaluation of sonar crown-rump length measurements. Br J Obstet Gynaecol 1975; 82: 702-710
13. Reinders A, Cuckson AC, Lee JT, Shennan AH: An accurate automated blood pressure device for use in pregnancy and pre-eclampsia: The Microlife 3BTO-A. BJOG 2005; 112: 915-920
14. Poon LC, Zymeri NA, Zamprakou A, Syngelaki A, Nicolaides KH: Protocol for measurement of mean arterial pressure at 11-13 weeks' gestation. Fetal Diagn Ther 2012; 31: 42-48
15. Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH: One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol 2000; 96: 559-564
16. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM: The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the international society for the study of hypertension in pregnancy (ISSHP). Hypertens Pregnancy 2001; 20:IX-XIV
17. Poon LCY, Volpe N, Muto B, Syngelaki A, Nicolaides KH: Birthweight with gestation and maternal characteristics in live births and stillbirths. Fetal Diagn Ther 2012; 32: 156-165
18. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data, ed 2. New York, Wiley, 2002
19. R Core Team: R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. URL 2013 http://www.R-project.org/ .
20. Van Asselt K, Gudmundsson S, Lindqvist P, Marsal K: Uterine and umbilical artery velocimetry in pre-eclampsia. Acta Obstet Gynecol Scand 1998; 77: 614-619
21. Ferrazzi E, Bulfamante G, Mezzopane R, Barbera A, Ghidini A, Pardi G: Uterine Doppler velocimetry and placental hypoxic-ischemic lesion in pregnancies with fetal growth restriction. Placenta 1999; 20: 389-394
22. Severi F, Bocchi C, Visentin A, Falco P, Cobellis L, Florio P, Zagonari S, Pilu G: Uterine and fetal cerebral Doppler predict the outcome of third-Trimester small-for-gestational age fetuses with normal umbilical artery Doppler. Ultrasound Obstet Gynecol 2002; 19: 225-228
23. Hernandez-Andrade E, Brodszki J, Lingman G, Gudmundsson S, Molin J, Marsal K: Uterine artery score and perinatal outcome. Ultrasound Obstet Gynecol 2002; 19: 438-442
24. Frusca T, Soregaroli M, Platto C, Enterri L, Lojacono A, Valcamonico A: Uterine artery velocimetry in patients with gestational hypertension. Obstet Gynecol 2003; 102: 136-140
25. Li H, Gudnason H, Olofsson P, Dubiel M, Gudmundsson S: Increased uterine artery vascular impedance is related to adverse outcome of pregnancy but is present in only onethird of late third-Trimester pre-eclamptic women. Ultrasound Obstet Gynecol 2005; 25: 459-463
26. Ghi T, Youssef A, Piva M, Contro E, Segata M, Guasina F, Gabrielli S, Rizzo N, Pelusi G, Pilu G: The prognostic role of uterine artery Doppler studies in patients with late-onset preeclampsia. Am J Obstet Gynecol 2009; 201: 36.e1-5
27. Lai J, Poon LC, Bakalis S, Chiriac R, Nicolaides KH: Systolic, diastolic and mean arterial pressure at 30-33 weeks in the prediction of preeclampsia. Fetal Diagn Ther 2013; 33: 173-181
28. Lai J, Poon LC, Pinas A, Bakalis S, Nicolaides KH: Uterine artery Doppler at 30-33 weeks' gestation in the prediction of preeclampsia. Fetal Diagn Ther 2013; 33: 156-163
29. Khong TY, De Wolf F, Robertson WB, Brosens I: Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93: 1049-1059
30. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, van Assche A: Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991; 98: 648-655
31. Roberts JM, Redman CW: Pre-eclampsia: More than pregnancy-induced hypertension. Lancet 1993; 341: 1447-1451
32. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA: Pathophysiology of hypertension During preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension 2001; 38: 718-722
33. Lai J, Pinas A, Poon LC, Agathokleous M, Nicolaides KH: Maternal serum placental growth factor, pregnancy-Associated plasma protein-A and free a-human chorionic gonadotrophin at 30-33 weeks in the prediction of pre-eclampsia. Fetal Diagn Ther 2013; 33: 164-172
34. Lai J, Garcia-Tizon Larroca S, Peeva G, Poon LC, Wright D, Nicolaides KH: Competing risks model in screening for preeclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30-33 weeks' gestation. Fetal Diagn Ther 2013, Epub ahead of print.